| Prof Bernard Flynn |
| Monash University |
| Inflammatory bowel disease |
| Drug |
Key outcomes:
- Term sheet for a VC-backed seed funding start-up company, $2.5m
- Monash Research Innovation Fund, $50,000
- Monash MIPS incubator investment, $50,000
“After being awarded the Dr. John Raftos AM Medal by NFMRI, Prof Flynn applied the $50,000 prize towards research investigating a potential treatment for inflammatory bowel disease. Despite receiving the funding in 2021, substantial progress is already taking place”